PHARMPROTECH HOLDING ApS: Financial statements 2024
CVR: 29174644
PHARMPROTECH HOLDING ApS (CVR 29174644) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -163,685 and a net result of DKK 5,877,922 compared with DKK 5,189,592 the year before. Equity amounted to DKK 34,598,042. The solvency ratio was 85.4%.
- Gross Profit
- -163,685 kr.
- Profit/Loss
- 5,877,922 kr.
- Equity
- 34,598,042 kr.
- Total Assets
- 40,530,917 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -164 t. | 5.9 mio. | 34.6 mio. | - |
| 2023 | - | -17 t. | 5.2 mio. | 28.8 mio. | - |
| 2022 | - | -10 t. | 5.6 mio. | 23.6 mio. | - |
| 2021 | - | -10 t. | 1.3 mio. | 18.1 mio. | - |
| 2020 | - | -6 t. | 5.4 mio. | 16.8 mio. | - |
How creditworthy is PHARMPROTECH HOLDING ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout PHARMPROTECH HOLDING ApS
PHARMPROTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2005. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tony Christensen. The company is owned by Tony Christensen. In 2025, the company reported a gross profit of DKK -767,188 and a net result of DKK 3,595,179 compared with DKK 5,877,922 the year before. Equity amounted to DKK 38,132,221.
